Overall rank by patents
#49,939
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 10 technology areas, active 2019–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
Raphas holds 5 US patents across 10 technology areas, rank #49,939 of 50,000 tracked assignees.
Raphas Co., Ltd. has been granted 5 US utility patents between 2019 and 2023, placing Raphas Co., Ltd. at rank #49,939 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.0 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Raphas Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Raphas sits between Raicam Driveline S.r.l. (5 patents, rank #49,935) and Ravas Europe B.v. (5 patents, rank #49,943) - the closest US assignees by grant volume. The composite Innovation Score of 26.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 2 in the 2015–2019 window, a +50% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Raphas Co., Ltd.'s 7.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Raphas Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
RAICAM DRIVELINE S.R.L.
5 patents
RALEIGH TACKLE LLC
5 patents
RAMAXEL TECHNOLOGY (SHENZHEN) LIMITED
5 patents
RAN Biotechnologies, Inc.
5 patents
RAPID OXYGEN COMPANY INC.
5 patents
RATIONAL INTERNATIONAL AG
5 patents
RAUCH LANDMASCHINENFABRIK GMBH
5 patents
RAVAS EUROPE B.V.
5 patents
RAPHAS CO., LTD.
5 patents
What this shows Raphas holds 5 patents at rank #49,939, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #49,939 in granted patent volume.
Other assignees with the most granted patents in Raphas's primary technology class.
Raphas's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
26 Top 81% higher than 19% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 2 | 40.0% |
| 2020 | 1 | 20.0% |
| 2023 | 2 | 40.0% |
Top 10 of 10 technology areas
Overall rank by patents
#49,939
Across all tracked assignees
26.0 out of 100
How to use this portfolio
Raphas's 5 grants land it in the top 81% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.